Vyepti 100 mg/ml, Konzentrat zur Herstellung einer Infusionslösung

7680679950016 CH-67995 Konzentrat
Vyepti 100 mg/ml, Konzentrat zur Herstellung einer Infusionslösung
Vyepti 100 mg/ml, Konzentrat zur Herstellung einer Infusionslösung
Vyepti 100 mg/ml, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1 x 1 ml
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
16/02/2023
Summary of Product Characteristics
Français
16/02/2023
Summary of Product Characteristics
Italien
16/02/2023

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
40.5 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 1257.55
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2022

Authorization holder

Lundbeck (Schweiz) AG

8152 Opfikon

Authorization information

Swissmedic authorization number
67995
Drug name
Vyepti, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
N02CD05
Authorization status
Z
Dispensing category
B
First authorization
11/10/2021
Authorization expiration date
10/10/2026
IT Number
02.05.1.
Domain
Human medicine
Field of application
Migräneprophylaxe

Package details

Description (FR)
VYEPTI conc perf 100 mg/ml flac 1 ml
Description (DE)
VYEPTI Inf Konz 100 mg/ml Durchstf 1 ml
Market launch
11/10/2021
Narcotic (BTM)
No